Breaking news in dry eye disease treatment, the U.S. Food and Drug Administration (FDA) has approved the first generic version of Restasis, cyclosporine ophthalmic emulsion 0.05%. This milestone, headed by Mylan Pharmaceuticals Inc., is poised to redefine the landscape of dry eye treatment. ...